NORTH AMERICAN MARKETS FOR FACIAL INJECTABLES 2010

This publication has been discontinued on February 9, 2012.

Below is the updated product.

Introduction

Abstract

The North American facial injectable market, comprising botulinum toxin, hyaluronic acid dermal filler, particle and polymer filler, and collagen filler product sales in Canada and the US, will undergo modest growth through 2014, fueled by high patient demand among American and Canadian consumers for procedures that help restore a more youthful appearance. The launch of new products, especially in the US market, will help promote market expansion as physicians gain access to new products and manufacturers more actively market their products to physicians and patients, facilitating heightened awareness. Greater competitive pressure throughout the forecast period will cause manufacturers to engage in marketing and promotional activity to differentiate their products from others, which will further fuel greater awareness among both physicians and patients. The economic recession, however, had a particularly strong impact on the North American facial injectable markets in the latter part of 2008, continuing through 2009. This caused many patients to delay or forego facial injectable treatment, thus hindering procedural growth. Upon economic recovery, which Millennium Research Group assumes will begin in January 2010, the facial injectable market will begin to experience positive market growth as patients increasingly opt for facial injectable treatment to restore a youthful appearance.

Methodology

Research Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

• Government Sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
• Facial Injectable Companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal Databases and Reports:
  • Previous reports on similar/related sources
• General Internet Searches, Medical Literature, and Newspaper/Magazine Searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various facial injectable market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry.

Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Marketrack Methodology

Millennium Research Group' s Facial Injectable Marketrack methodology is based on recruiting plastic surgeons, dermatologists, and other aesthetic practitioners to provide data on their facilities' activities in terms of product usage, procedure volumes, and prices paid for facial injectable products.

Key benefits of Marketrack data collection include the following:

A dedicated team of in-house Marketrack researchers ensure high-quality data gathering, verification, and analysis. Our researchers are native speakers of the languages in each of the countries they research.

An extensive global network of cosmetic facilities (dermatology, plastic surgery, and medispas) that recognize the Marketrack brand and engage in ongoing research.

Regular client feedback on all projects, leading to continuous improvements in data quality, presentation, usability, and methodology. Since the initiation of Facial Injectable Marketrack in June 2006, subscribers have requested coverage to extend across Europe and Latin and North America.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 NORTH AMERICAN FACIAL INJECTABLE MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Key Report Updates
  • 1.2.2 Economic Assumptions for the Forecast Period
  • 1.2.3 Market Definitions
  • 1.2.4 Product Overview
  • 1.2.5 Procedures
    • 1.2.5.1 Procedures by Injector Type
    • 1.2.5.2 Procedures by Injectable Type
      • Botulinum Toxin Procedures
      • Hyaluronic Acid Dermal Filler Procedures
      • Particle and Polymer Filler Procedures
      • Collagen Filler Procedures
    • 1.2.5.3 Procedures by Facial Area
      • Glabellar Complex Augmentation Procedures
      • Nasolabial Fold Augmentation Procedures
      • Forehead Augmentation Procedures
      • Periorbital Area Augmentation Procedures
      • Lip Augmentation Procedures
      • Mouth Area Augmentation Procedures
      • Cheek Augmentation Procedures
  • 1.2.6 Market Forecast
    • 1.2.6.1 US Facial Injectable Market
    • 1.2.6.2 Canadian Facial Injectable Market
  • 1.2.7 Market Drivers and Limiters
    • 1.2.7.1 Market Drivers
    • 1.2.7.2 Market Limiters
• 1.3 Competitive Analysis
  • 1.3.1 Competitive Landscape
  • 1.3.2 Market Shares
  • 1.3.3 Competitor Discussions (in Alphabetical Order)
    • Allergan
    • BioForm Medical
    • Ipsen
    • Medicis Pharmaceutical
    • Q-Med
    • sanofi-aventis
    • Other

2.0 BOTULINUM TOXIN MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Product Overview
  • 2.2.2 Botulinum Toxin Procedures by Facial Area
  • 2.2.3 Market Forecast
  • 2.2.4 Market Drivers and Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Competitive Landscape
  • 2.3.2 Market Shares
  • 2.3.3 Emerging Competitors

3.0 HYALURONIC ACID DERMAL FILLER MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Product Overview
  • 3.2.2 Hyaluronic Acid Dermal Filler Procedures by Facial Area
  • 3.2.3 Market Forecast
  • 3.2.4 Market Drivers and Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Competitive Landscape
  • 3.3.2 Market Shares
  • 3.3.3 Emerging Competitors

4.0 PARTICLE AND POLYMER FILLER MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Product Overview
    • 4.2.1.1 Particle Fillers
    • 4.2.1.2 Polymer Fillers
  • 4.2.2 Particle and Polymer Filler Procedures by Facial Area
  • 4.2.3 Market Forecast
  • 4.2.4 Market Drivers and Limiters
• 4.3 Competitive Analysis
  • 4.3.1 Competitive Landscape
  • 4.3.2 Market Shares
  • 4.3.3 Emerging Competitors

5.0 COLLAGEN FILLER MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Product Overview
  • 5.2.2 Collagen Filler Procedures by Facial Area
  • 5.2.3 Market Forecast
  • 5.2.4 Market Drivers and Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Competitive Landscape
  • 5.3.2 Market Shares
  • 5.3.3 Emerging Competitors

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Facial Injectable Market, North America (US$), 2008 - 2014
• Exhibit 2: BTX Market, by Country, North America (US$), 2008 - 2014
• Exhibit 3: HA Dermal Filler ASPs, by Country, North America (US$), 2008 - 2014
• Exhibit 4: PPF ASP Growth, by Country, North America, 2009 - 2014
• Exhibit 5: Collagen Filler Market, by Country, North America (US$), 2009 and 2014
• Exhibit 6: Leading Competitors in the Facial Injectable Market, North America, 2009

METHODOLOGY

• Exhibit 7: Currency Exchange Rates, 2009

CHAPTER 1: NORTH AMERICAN FACIAL INJECTABLE MARKET

• Exhibit 8: Facial Injectable Market, by Country, North America (US$), 2008 - 2014
• Exhibit 9: Key Report Updates, 2010
• Exhibit 10: Key Report Updates, 2009 (Cont' d)
• Exhibit 11: Volume per Procedure, by Product
• Exhibit 12: Common Facial Injectable Products, by Type, North America, 2009
• Exhibit 13: Common Facial Injectable Indications, by Type, North America, 2009
• Exhibit 14: Facial Injectable Procedures, by Segment, North America, 2008 - 2014
• Exhibit 15: Facial Injectable Procedures, by Segment, US, 2008 - 2014
• Exhibit 16: Facial Injectable Procedures, by Segment, Canada, 2008 - 2014
• Exhibit 17: BTX Procedures, by Country, North America, 2008 - 2014
• Exhibit 18: HA Dermal Filler Procedures, by Country, North America, 2008 - 2014
• Exhibit 19: PPF Procedures, by Country, North America, 2008 - 2014
• Exhibit 20: Collagen Filler Procedures, by Country, North America, 2008 - 2014
• Exhibit 21: Facial Injectable Procedure Breakdown, by Facial Area and Segment, North America, 2009
• Exhibit 22: Facial Injectable Procedure Breakdown, by Facial Area and Country, North America, 2009
• Exhibit 23: Facial Injectable Market, by Country, North America (US$ and CA$), 2008 - 2014
• Exhibit 24: Facial Injectable Market, by Segment, US (US$), 2008 - 2014
• Exhibit 25: Facial Injectable Market, BTX vs. Dermal Fillers, US (US$), 2008 - 2014
• Exhibit 26: Facial Injectable Market, by Segment, Canada (US$ and CA$), 2008 - 2014
• Exhibit 27: Facial Injectable Market, BTX vs. Dermal Fillers, Canada (US$ and CA$), 2008 - 2014
• Exhibit 28: Drivers and Limiters of the Facial Injectable Market, North America
• Exhibit 29: Leading Competitors in the Facial Injectable Market, by Country, as a % of Total, North America, 2009

CHAPTER 2: BOTULINUM TOXIN MARKET

• Exhibit 30: BTX Market, by Country, North America (US$), 2008 - 2014
• Exhibit 31: Common BTX Products, North America, 2009
• Exhibit 32: Emerging BTX Products, North America, 2009
• Exhibit 33: BTX Procedure Breakdown, by Facial Area and Country, as a % Total, North America, 2009
• Exhibit 34: BTX Market, by Country, North America (US$), 2008 - 2014
• Exhibit 35: BTX Market, by Country, North America (US$ and CA$), 2008 - 2014
• Exhibit 36: BTX Market Growth, by Country, North America, 2009 - 2014
• Exhibit 37: Drivers of the BTX Market, North America
• Exhibit 38: Drivers of the BTX Market, North America (Cont' d)
• Exhibit 39: Limiters of the BTX Market, North America
• Exhibit 40: Leading Competitors in the BTX Market, by Country, as a % of Total, North America, 2009

CHAPTER 3: HYALURONIC ACID DERMAL FILLER MARKET

• Exhibit 41: HA Dermal Filler Market, by Country, North America (US$), 2008 - 2014
• Exhibit 42: Common HA Dermal Filler Products, North America, 2009
• Exhibit 43: Common HA Dermal Filler Products, North America, 2009 (Cont' d)
• Exhibit 44: Emerging HA Dermal Filler Products, North America, 2009
• Exhibit 45: HA Dermal Filler Procedure Breakdown, by Facial Area and Country, as a % of Total, North America, 2009
• Exhibit 46: HA Dermal Filler Market, by Country, North America (US$), 2008 - 2014
• Exhibit 47: HA Dermal Filler Market, by Country, North America (US$ and CA$), 2008 - 2014
• Exhibit 48: HA Dermal Filler Market Growth, by Country, North America, 2009 - 2014
• Exhibit 49: Drivers of the HA Dermal Filler Market, North America
• Exhibit 50: Drivers of the HA Dermal Filler Market, North America (Cont' d)
• Exhibit 51: Limiters of the HA Dermal Filler Market, North America
• Exhibit 52: Leading Competitors in the HA Dermal Filler Market, by Country, as a % of Total, North America, 2009

CHAPTER 4: PARTICLE AND POLYMER FILLER MARKET

• Exhibit 53: PPF Market, by Country, North America (US$), 2008 - 2014
• Exhibit 54: Common PPF Products, North America, 2009
• Exhibit 55: Common PPF Products, North America, 2009 (Cont' d)
• Exhibit 56: Emerging PPF Products, North America
• Exhibit 57: PPF Procedure Breakdown, by Facial Area and Country, as a % of Total, North America, 2009
• Exhibit 58: PPF Market, by Country, North America (US$), 2008 - 2014
• Exhibit 59: PPF Market, by Country, North America (US$ and CA$), 2008 - 2014
• Exhibit 60: PPF Market Growth, by Country, North America, 2009 - 2014
• Exhibit 61: Drivers of the PPF Market, North America
• Exhibit 62: Drivers of the PPF Market, North America (Cont' d)
• Exhibit 63: Limiters of the PPF Market, North America
• Exhibit 64: Limiters of the PPF Market, North America (Cont' d)
• Exhibit 65: Leading Competitors in the PPF Market, by Country, as a % of Total, North America, 2009

CHAPTER 5: COLLAGEN FILLER MARKET

• Exhibit 66: Collagen Filler Market, by Country, North America (US$), 2008 - 2014
• Exhibit 67: Common Collagen Filler Products, North America, 2009
• Exhibit 68: Common Collagen Filler Products, North America, 2009 (Cont' d)
• Exhibit 69: Emerging Collagen Filler Products, North America, 2009
• Exhibit 70: Collagen Filler Procedure Breakdown, by Facial Area and Country, as a % of Total, North America, 2009
• Exhibit 71: Collagen Filler Market, by Country, North America (US$), 2008 - 2014
• Exhibit 72: Collagen Filler Market, by Country, North America (US$ and CA$), 2008 - 2014
• Exhibit 73: Collagen Filler Market Growth, by Country, North America, 2009 - 2014
• Exhibit 74: Drivers of the Collagen Filler Market, North America
• Exhibit 75: Limiters of the Collagen Filler Market, North America
• Exhibit 76: Leading Competitors in the Collagen Filler Market, by Country, as a % of Total, North America, 2009

APPENDIX B: SUPPLEMENTAL EXHIBITS

• Exhibit 77: Facial Injectable Market, North America (US$), 2008 - 2014 (Detailed Format)
• Exhibit 78: BTX Market, by Country, North America (US$), 2008 - 2014 (Detailed Format)
• Exhibit 79: HA Dermal Filler ASPs, by Country, North America (US$), 2008 - 2014 (Detailed Format)
• Exhibit 80: PPF ASP Growth, by Country, North America, 2009 - 2014 (Detailed Format)
• Exhibit 81: Collagen Filler Market, by Country, North America (US$), 2009 and 2014 (Detailed Format)

Related Reports